UCLA Biodesign Fellow Dr. Jose Morales Joins CLS FAST Advisory Program through MedTech Color
UCLA Biodesign Accelerator Fellow, Dr. Jose Morales, founder of JUAD NextGen, was selected for the 2021 California Life Sciences FAST Program in partnership with the MedtechColor Pitch Competition. JUAD NextGen is developing neuroendovascular theranostic devices for neurological disorders and diseases.
MedTech Color, a non-profit organization with a mission to advance the representation of persons of color in the medtech industry, has partnered with California Life Sciences (CLS), the state’s most influential and impactful life sciences membership organization, to launch a MedTech Color Track as part of the Fall FAST program. Founded in 2013, FAST provides select early-stage startups and academic researchers with intensive team review and coaching to perfect their business model and create a compelling commercialization strategy.
California Life Sciences selected Dr. Jose Morales, founder of JUAD NextGen, from the 2021 MedtechColor Pitch Competition for the 12-week customized advisory program. The MedTech Color (MTC) Annual Pitch Competition, aims to celebrate innovative ideas from early-stage start-up companies who have raised less than one million dollars – providing finalists with not only direct funding, but mentorship from medtech industry leaders.